| |
| |
|
|
A BILL TO BE ENTITLED
|
|
|
AN ACT
|
|
|
relating to the requirements for the labeling and dispensing of a |
|
|
prescription drug or biological product. |
|
|
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: |
|
|
SECTION 1. Section 562.006, Occupations Code, is amended by |
|
|
amending Subsections (b) and (f) and adding Subsection (g) to read |
|
|
as follows: |
|
|
(b) In addition to the information required by Subsection |
|
|
(a), the label on the dispensing container of a drug or biological |
|
|
product dispensed by a Class A or Class E pharmacy must [indicate]: |
|
|
(1) indicate: |
|
|
(A) the name, address, and telephone number of |
|
|
the pharmacy; |
|
|
(B) [(2)] the date the prescription is |
|
|
dispensed; |
|
|
(C) [(3)] the name of the prescribing |
|
|
practitioner; |
|
|
(D) [(4)] the name of the patient or, if the drug |
|
|
or biological product was prescribed for an animal, the species of |
|
|
the animal and the name of the owner; |
|
|
(E) [(5)] instructions for use; |
|
|
(F) [(6)] the quantity dispensed; |
|
|
(G) [(7)] if the drug or biological product is |
|
|
dispensed in a container other than the manufacturer's original |
|
|
container, the date after which the prescription should not be |
|
|
used, determined according to criteria established by board rule |
|
|
based on standards in the United States Pharmacopeia-National |
|
|
Formulary; and |
|
|
(H) [(8)] any other information required by |
|
|
board rule; and |
|
|
(2) include, in a format accessible to the patient |
|
|
through a mobile Internet application or assistive technology |
|
|
electronic device available to the patient at no cost, the |
|
|
information described by Subdivision (1) and information regarding |
|
|
potential side effects and contraindicated medications. |
|
|
(f) The [board shall adopt rules requiring the] label on a |
|
|
dispensing container must [to] be in plain language and printed in |
|
|
Times New Roman with a minimum of 12-point [an easily readable] font |
|
|
size [for the consumer]. |
|
|
(g) A pharmacist at a Class A or Class E pharmacy shall, on a |
|
|
patient's request, provide to the patient a large-print data sheet |
|
|
containing: |
|
|
(1) the information required under Subsection (b)(1) |
|
|
to be on the label on a dispensing container of a drug or biological |
|
|
product dispensed to the patient; and |
|
|
(2) information regarding potential side effects and |
|
|
contraindicated medications for the drug or biological product |
|
|
dispensed to the patient. |
|
|
SECTION 2. Not later than January 1, 2026, the Texas State |
|
|
Board of Pharmacy shall adopt any rules necessary to implement the |
|
|
changes in law made by this Act. |
|
|
SECTION 3. The changes in law made by this Act apply only to |
|
|
a drug or biological product dispensed on or after March 1, 2026. A |
|
|
drug or biological product dispensed before March 1, 2026, is |
|
|
governed by the law in effect immediately before the effective date |
|
|
of this Act, and the former law is continued in effect for that |
|
|
purpose. |
|
|
SECTION 4. This Act takes effect September 1, 2025. |